U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Nucleic Acid
Created
by admin
on Wed Apr 02 17:30:25 GMT 2025
Edited
by admin
on Wed Apr 02 17:30:25 GMT 2025
Nucleic Acid Type mRNA VACCINE
Sequence Origin VIRAL
Sequence Type COMPLETE
Record UNII
N36VHK46PR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Raxtozinameran
INN  
Official Name English
BNT162b2 Omicron (XBB.1.5)
Preferred Name English
Raxtozinameran [WHO-DD]
Common Name English
RNA (recombinant 5?-[1,2-[(3?-O-methyl)m7G-(5??5?)-ppp-Am]]-capped all uridine?N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 spike glycoprotein secretory signal peptide plus codon-optimized pre-fusion spike glycoprote
Common Name English
RBP-020.2 4 (XBB.1.5 variant)
Common Name English
messenger RNA (mRNA), 5'-capped, encoding a full-length, codon-optimised pre-fusion stabilised conformation variant (K982P and V983P) of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) spike (S) glycoprotein (Omicron sub-lineage XBB.1.5;
Common Name English
raxtozinameran [INN]
Common Name English
Code System Code Type Description
INN
13075
Created by admin on Wed Apr 02 17:30:25 GMT 2025 , Edited by admin on Wed Apr 02 17:30:25 GMT 2025
PRIMARY
CAS
2887554-49-4
Created by admin on Wed Apr 02 17:30:25 GMT 2025 , Edited by admin on Wed Apr 02 17:30:25 GMT 2025
PRIMARY
NCI_THESAURUS
C203101
Created by admin on Wed Apr 02 17:30:25 GMT 2025 , Edited by admin on Wed Apr 02 17:30:25 GMT 2025
PRIMARY
SMS_ID
300000051270
Created by admin on Wed Apr 02 17:30:25 GMT 2025 , Edited by admin on Wed Apr 02 17:30:25 GMT 2025
PRIMARY
FDA UNII
N36VHK46PR
Created by admin on Wed Apr 02 17:30:25 GMT 2025 , Edited by admin on Wed Apr 02 17:30:25 GMT 2025
PRIMARY
Sugar Site Range Site Count
D-Ribose (RNA) 1_1-1_4271 4271 / 4271
Linkage Site Range Site Count
Phosphate 1_2-1_4271 4270 / 4270
Related Record Type Details
MUTANT->PARENT
TARGET ORGANISM->VACCINE ANTIGEN
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
NUCLEOSIDE_SUBSTITUTION U N1-METHYLPSEUDOURIDINE 09RAD4M6WF
NUCLEOTIDE SUBSTITUTION m2-7,3’-OGppp(m1-2’-O)Ap mRNA CAP VNP8CZY34V